About Kopran
Kopran is a company based in Mumbai (India) founded in 1997. The company has 1,020 employees as of March 31, 2024. Kopran operates in a competitive market with competitors including Almac Group, Asymchem, Seqens, Aurobindo Pharma and Aptuit, among others.
- Headquarter Mumbai, India
- Employees 1020 as on 31 Mar, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Kopran Limited
-
Annual Revenue
$73.16 M (USD)2.37as on Mar 31, 2025
-
Net Profit
$4.51 M (USD)-24.34as on Mar 31, 2025
-
EBITDA
$8.35 M (USD)-9.22as on Mar 31, 2025
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
1020
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Kopran
Kopran is a publicly listed company on the NSE with ticker symbol KOPRAN in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of Kopran
Detailed funding history for Kopran
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Kopran
Investment portfolio details for Kopran
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Kopran
Detailed financials for Kopran
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Kopran Comparisons
Peer comparison for Kopran
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Kopran
Kopran operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Almac Group, Asymchem, Seqens, Aurobindo Pharma and Aptuit, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Integrated CDMO services for biopharma R&D and manufacturing are offered.
|
|
| Locked | Locked | Locked |
APIs and peptides are developed and manufactured by Asymchem.
|
|
| Locked | Locked | Locked |
Contract manufacturing services for small molecules and peptides are provided.
|
|
| Locked | Locked | Locked |
Generic biocatalytic solutions are provided for pharmaceutical applications.
|
|
| Locked | Locked | Locked |
Contract research and development services for small molecules are offered.
|
|
| Locked | Locked | Locked |
APIs manufacturing and formulation services are provided in therapeutic segments.
|
Detailed competitors of Kopran
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Kopran
Complete news archive for Kopran
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kopran
Kopran was founded in 1997.
Kopran is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
As of Mar 31, 2024, the latest employee count at Kopran is 1,020.
Annual revenue of Kopran is $73.16M as on Mar 31, 2025.
Kopran was founded in 1997 and is headquartered in Mumbai, India. Operations focus on the pharmaceutical sector, where finished dosage forms are produced, active pharmaceutical ingredients are researched and developed, and consumer healthcare items are handled. Coverage extends to therapeutic categories such as anthelmintics, antibiotics, cardiovascular treatments, and gastroenterology solutions. More than 500 products form the portfolio, while formulation development services are offered for regulated markets.
Kopran's top competitors include Concord Biotech, Almac Group and Indoco Remedies.
Yes, Kopran is publicly traded on NSE under the ticker symbol KOPRAN.
The ticker symbol of Kopran is KOPRAN on NSE.